Cresco Labs Begins Trading on the Canadian Securities Exchange Under Ticker Symbol ‘CL’
New Investors Website Launched at crescolabs.com/investors
Cresco Labs Inc., one of the largest vertically integrated multistate cannabis operators in the United States, begins trading
today on the Canadian Securities Exchange ("CSE") under the ticker symbol "CL."
“Today marks the beginning of an exciting new chapter in Cresco’s growth story,” said Charles Bachtell, CEO of Cresco Labs. “Not
only do we now have access to the public equity markets to fund our expansion, but we also offer the opportunity for equity
investors to own shares in a company that we believe is well positioned to generate strong growth and attractive shareholder
returns in the years ahead.”
Investors, media and other interested parties are invited to visit Cresco’s new Investors website at
investors.crescolabs.com to view company information and request automated email alerts for future news and public filings.
About Cresco Labs, LLC:
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a
demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis with operations in six
states (Illinois, Ohio, Pennsylvania, Nevada, California and Arizona) and approval pending for acquisitions in three more states
(New York, Massachusetts, Maryland), the company focuses on entering markets with outsized demand potential, significant supply
constraints and high barriers to entry. Its unparalleled speed-to-market gives Cresco a distinct competitive advantage as it
replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a well-defined
brand strategy that is tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef
inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and
may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of
the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements
are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs
regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's
control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking
terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’
‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s
forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual
results, performance or achievements to be materially different from any future results, performance or achievements expressed or
implied by the forward-looking statements, including but not limited to: the illegality of the Company’s business at the U.S.
federal level and the risk of prosecution; the U.S. State level regulatory uncertainty; clearing of the securities; risks to
Canadian investors being barred from entering the U.S.; restricted access to banking; the availability of additional financing; the
lack of approval by the U.S. Food and Drug Administration; constraints on marketing products; limited trademark protection;
unfavorable tax treatment; the tax classification of the Company in the U.S.; lack of access to U.S. bankruptcy protections;
proceeds of crime statutes; liability and enforcement; risks inherent in the agricultural business; environmental risks and
regulations; access to third-party service providers; product liability; personal information breaches; liability for fraudulent or
illegal activity by employees, contractors and consultants; the Company’s limited operating history; the difficulty quantifying the
target market; planned expansion; the limited market for securities; security risks; public and consumer perceptions; contracts may
not be legally enforceable; restricted transfer of securities; voting control; reliance on management; risks related to the
Illinois Medical Cannabis Pilot Program; reliance on management; the risks discussed under "Risk Factors" in the company’s CSE
Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned
that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the
Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares.
The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the
Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise.
Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not
imply that there has been no change in the affairs of the Company after the date hereof or create any duty to update or supplement
any information provided in this press release or otherwise.
Media
Cresco Labs:
Jason Erkes
Chief Communications Officer
je@crescolabs.com
Financial Profiles:
Debbie Douglas
949.375.3436
ddouglas@finprofiles.com
Investors
Cresco Labs:
Aaron Miles
Vice President, Investor Relations
310.622.8255
Financial Profiles:
Kim Esterkin, Kristen Papke, Ashley Grossman
CLinvestors@finprofiles.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20181203005369/en/